Novavax Signs Licensing Agreement With Pfizer for Vaccine Adjuvant Technology
by Natasha Hobley
Novavax, Inc. and Pfizer, Inc. have signed a licensing arrangement allowing Pfizer access to Novavax’s Matrix-M adjuvant technology to boost immune response ...
Researchers Found Variable Aluminum Content in Infant Vaccines Inaccurately Measured and Reported
by Kate Raines

Story Highlights Christopher Exley, PhD has hundreds of peer-reviewed articles and a well-established international reputation for his expertise on the ...
Half a Million Sharks Could Die to Produce Squalene Adjuvants for COVID-19 Vaccines
by Rishma Parpia

Story Highlights A shark conservation group is calling for alternatives to using squalene harvested from the liver of sharks as ...
Vaccines Rely on Horseshoe Crab’s Blue Blood for Purity
by Barbara Cáceres

Every spring, 500,000 Atlantic Horseshoe Crabs are collected by four biopharmaceutical companies as they crawl to the mid-Atlantic beaches to ...
How Vaccines are Made
by Marco Cáceres

Opinion | If you do a Google search on the topic of how vaccines are made, the first hit you ...
Study Reveals Baby Food Contains Heavy Metals
by Rishma Parpia

Story Highlights A recent study released by Healthy Babies Bright Futures showed that 95 percent of baby foods that were ...
FluMist “Reformulated” But Still Mostly the Same Old Vaccine
by Marco Cáceres

On June 22, 2016, the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) recommended against ...
Big Gaps in Toxicity Testing for Vaccine Safety
by Rishma Parpia

The phrase "vaccines are safe and effective" suggests that the use of small amounts of toxic ingredients in vaccines such ...
New Human Fetal Cell Line Available for Vaccine Production
by Marco Cáceres

Since the 1960s, a number of vaccines have been manufactured using "human-diploid fibroblast cell cultures"—cells from tissue of aborted human ...
In this section
Latest
Popular
Comments
Latest
Popular
Comments
- Karen Brackenon FDA Panel Backs mFlusiva mRNA Flu Shot for Elderly
- Tomon FDA Panel Backs mFlusiva mRNA Flu Shot for Elderly
- Tenaya Asanon Merck Settles Gardasil Vaccine Injury Lawsuit for $50 Million
- Jayon Study Finds Ivermectin and Mebendazole Beneficial in Treating Cancer
- Eroneon The Debate Over ADHD and Doctor Prescribed Video Games











